Last update 08 May 2025

Epidermolysis Bullosa Pruriginosa

Basic Info

Synonyms
DEB pruriginosa, DEB, PRURIGINOSA, DEB-Pr
+ [10]
Introduction
A rare dystrophic epidermolysis bullosa (DEB) characterized by generalized or localized skin lesions associated with severe, if not intractable, pruritus.

Related

1
Drugs associated with Epidermolysis Bullosa Pruriginosa
Pumecitinib
Target
JAK1 x JAK2
Mechanism
JAK1 inhibitors [+1]
Active Org.
Beijing Puqi Pharmaceutical Technology Co Ltd.Beijing Puqi Pharmaceutical Technology Co Ltd.
Originator Org.
Beijing Puqi Pharmaceutical Technology Co Ltd.Beijing Puqi Pharmaceutical Technology Co Ltd.
Active Indication
Dermatitis, Atopic [+11]
Inactive Indication-
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with Epidermolysis Bullosa Pruriginosa
Login to view more data
100 Translational Medicine associated with Epidermolysis Bullosa Pruriginosa
Login to view more data
0 Patents (Medical) associated with Epidermolysis Bullosa Pruriginosa
Login to view more data
130
Literatures (Medical) associated with Epidermolysis Bullosa Pruriginosa
01 Mar 2025Clinics in Dermatology
Prurigo nodularis phenotype in the bullous dermatoses spectrum
01 Jan 2025The Journal of Dermatology
A case of epidermolysis bullosa pruriginosa with a COL7A1 gene mutation successfully treated with upadacitinib
01 Nov 2024Indian Journal of Dermatology
Successful Management of Epidermolysis Bullosa Pruriginosa with Oral Thalidomide: A Case Report of Rare Dystrophic EB Subset

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free